NEOTHERAPEUTICS (NEOT) (NEOTW) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW)

NEOT 1.919

+4.3%

Jan 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gerald Underwood who wrote (674)	6/2/1999 2:23:00 PM
From: Marty	Read Replies (1) of 705

I saw the release and bought some stock and warrants. It is great news. As long as the tests confirm that Neotherapeutics has what it thinks it has, we are in great shape. It looks like they have even better results than they expected. My first thought when I learned that they had a drug that could improve the memory in laboratory animals was that this could be a breakthrough drug. Now the drug has demonstrated that it can be administered and absorbed easily, it passed the toxicity tests, and now the early efficacy tests are fantastic. I wish we could get some more details on the tests comparisons to other drugs, and clear explanations of the real significance of the findings. When they say, "statistically significant positive differences" and "marked improvement" for example, it means a lot more to them than it does to laymen. A real breakthrough drug with a new approach and possibly even useful in other applications is a very big deal. No doubt the results will be reviewed in critical detail by the bio community, as it should be but, as we said all along ... so far, so good. Now it is "So far, better than just good."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next